Chinese Journal of Antituberculosis ›› 2018, Vol. 40 ›› Issue (7): 736-743.doi: 10.3969/j.issn.1000-6621.2018.07.013
• Original Articles • Previous Articles Next Articles
Received:
2017-12-27
Online:
2018-07-10
Published:
2018-09-07
Contact:
Zhan-qiang SUN
E-mail:sunzhanqiang@126.com
Zhan-qiang SUN. Development and assessment of the XTT/mPMS combination system for the rapid anti-mycobacteria drug susceptibility testing[J]. Chinese Journal of Antituberculosis, 2018, 40(7): 736-743. doi: 10.3969/j.issn.1000-6621.2018.07.013
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2018.07.013
[1] | World Health Organization . Global tuberculosis report 2017. Geneva: World Health Organization, 2017. |
[2] |
Singh JA, Bhan A . The ethics of national tuberculosis programmes in low-income countries not rolling out Xpert ®MTB/RIF . Int J Tuberc Lung Dis, 2011,15(12):1563.
doi: 10.5588/ijtld.11.0728 URL |
[3] |
Khan A, Sarkar D . A simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli. J Microbiol Me-thods, 2008,73(1):62-68.
doi: 10.1016/j.mimet.2008.01.015 URL |
[4] |
Tan Y, Su B, Zheng H , et al. Prothionamide susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTECMGIT 960 system. Eur J Clin Microbiol Infect Dis, 2017,36(5):779-782.
doi: 10.1007/s10096-016-2859-6 URL |
[5] |
Singh S, Kumar P, Sharma S , et al. Rapid identification and drug susceptibility testing of Mycobacterium tuberculosis: Standard operating procedure for non-commercial assays: Part 3: colorimetric redox indicator assay v1.3.12. J Lab Physicians, 2012,4(2):120-126.
doi: 10.4103/0974-2727.105594 URL |
[6] |
Singh U, Akhtar S, Mishra A , et al. A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents. J Microbiol Methods, 2011,84(2):202-207.
doi: 10.1016/j.mimet.2010.11.013 URL |
[7] |
陆宇, 王彬, 郑梅琴 , 等. 应用Alamar Blue和MTT测定抗结核药物最低抑菌浓度的研究. 中国防痨杂志, 2007,29(6):499-501.
doi: 10.3969/j.issn.1000-6621.2007.06.007 URL |
[8] |
Berridge MV, Herst PM, Tan AS . Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev, 2005,11:127-152.
doi: 10.1016/S1387-2656(05)11004-7 URL |
[9] |
De Logu A, Uda P, Pellerano ML , et al. Comparison of two rapid colorimetric methods for determining resistance of Mycobacterium tuberculosis to rifampin, isoniazid, and streptomycin in liquid medium. Eur J Clin Microbiol Infect Dis, 2001,20(1):33-39.
doi: 10.1007/PL00011234 URL |
[10] | 张朝宝, 马峻, 温子禄 , 等. XTT/mPMS组合显色系统用于抗分枝杆菌药物筛选的性能评估. 临床检验杂志, 2013,31(5):344-348. |
[11] |
Tsukatani T, Suenaga H, Higuchi T , et al. Colorimetric cell proliferation assay for microorganisms in microtiter plate using water-soluble tetrazolium salts. J Microbiol Methods, 2008,75(1):109-116.
doi: 10.1016/j.mimet.2008.05.016 URL |
[12] | De Logu A, Borgna R, Uda P , et al. The 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay as rapid colorimetric method for determination of antibio-tic susceptibility of clinical Mycobacterium tuberculosis isolates in liquid medium. Clin Lab, 2003,49(7/8):357-365. |
[1] | LIANG Rui-yun, FANG Wei-jun, REN Hui-li, LI Hui-ru, ZHANG Hui. Study on CT manifestations of non-tuberculous mycobacterium pulmonary disease patients with and without diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 962-967. |
[2] | Chinese Antituberculosis Association, Schools and Children Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis . Expert consensus of clinical application of the recombinant Mycobacterium tuberculosis fusion protein (EC) [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 761-768. |
[3] | Beijing Chest Hospital, Capital Medical University, Non-tuberculous Mycobacterial Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis . Expert consensus on off-label use of drugs for non-tuberculous mycobacteria [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 769-787. |
[4] | YANG Lei, WEI Fen, ZHANG Kai, QIU Jing-jing, WANG Ying-ying, DU Wei-xin, LU Jin-biao, TAO Li-feng, PU Jiang. Stability and efficacy study of recombinant Mycobacterium tuberculosis fusion protein (EC) [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 799-806. |
[5] | ZHANG Kai, TAO Li-feng, WEI Fen, DU Wei-xin, QIU Jing-jing, CHEN Wei, CHEN Bao-wen, ZHU Yin-meng, CHENG Xing, SU Cheng, ZHONG Zai-xin, LU Jin-biao, PU Jiang. Immune characteristics and preclinical animal safety studies of recombinant Mycobacterium tuberculosis fusion protein(EC) [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 807-813. |
[6] | ZHANG Kai, SHEN Xiao-bing, TAO Li-feng, WEI Fen, CHEN Bao-wen, QIU Jing-jing, CHEN Wei, LU Jin-biao, ZHU Yin-meng, CHENG Xing, ZHONG Zai-xin, ZHAO Ai-Hua, PU Jiang. Establishment of quality standards for recombinant Mycobacterium tuberculosis fusion protein [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 814-820. |
[7] | DU Wei-xin, WEI Fen, LU Jin-biao, ZHAO Ai-hua, PU Jiang, WANG Guo-zhi, XU Miao. Preliminary establishment of national reference of the freeze-dried recombinant Mycobacterium tuberculosis allergen for the bulk potency evaluation [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 826-831. |
[8] | CHEN Feng-fang, MA Jun, HUANG Jin, YIN Hong-yun, SHA Wei, YANG Guang-hong, FENG Yong-hong. Preliminary study on establishing the diagnostic model for smear negative tuberculosis and stage Ⅰ/Ⅱ sarcoidosis with hilar/mediastinal lymphadenopathy and positive T-SPOT.TB results [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 832-837. |
[9] | DUAN Li-ming, DING Chao, LIU Yu-gang, WEI Lin, GU Zhen-ning. Application value of video-assisted thoracoscopic surgery in the treatment of chronic tuberculous empyema [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 850-853. |
[10] | CHEN Ning, SUN Lin, SHEN A-dong, HE Qiu-shui. Possible causes of infection after BCG vaccination [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 869-873. |
[11] | QU Meng-jin, LIANG Zheng-min, WANG Yuan-zhi, ZHOU Xiang-mei. Research progress of carbohydrate metabolism of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 874-879. |
[12] | SUN Qing, HUANG Hai-rong, WANG Gui-rong. In vitro activities and drug resistance mechanisms of bedaquiline, clofazimine and delamanid against common pathogenic non-tuberculous mycobacteria [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 880-884. |
[13] | SONG Yi-meng, LI Yuan-chun, HE Wen-cong, HE Ping, BAO Jing-jing, LIU Chun-fa, LIU Dong-xin, WANG Xin-yang, ZHAO Yan-lin, LI Yan-ming. Cost analysis of fluorescence PCR probe melting curve technique for the detection of Mycobacterium tuberculosis resistance in China [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 712-717. |
[14] | BAO Xun-di, JIANG Yue, LIANG Suo, CHENG Hong-yan, XIA Guang-xiu, WANG Chao, YE Qian, WANG Shu, WANG Qing. Analysis of the clinical isolation rate, population distribution and drug resistance of non-tuberculous mycobacteria in Anhui [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 718-724. |
[15] | ZHANG Jie, REN Yi-xuan, PAN Li-ping, ZHANG Zong-de. Application of whole genome sequencing in research of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 737-740. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||